In this study, we first analyzed the gene expression profile of STAM mice at different stages of NAFLD progression and observed that the activation of the LPL/FABP4/CPT1 molecular axis that controls lipid metabolism may be involved in the progression of NASH to HCC. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.